Fermentalg (FALG) Q3 2025 TU earnings summary

Executive summary

• Revenue reached €9.6 million at the end of September 2025, with annual revenue expected to be around €13 million, up from €11.5 million in 2024.

• Double-digit growth target for 2025 reaffirmed, with significant catalysts anticipated for 2026, including new product launches and market expansion.

• Commercial rollout of the Origins™ range expanded into infant nutrition and aquaculture, now accounting for 40% of annual sales.

Financial highlights

• Revenue stable at €9.6 million as of September 2025, despite macroeconomic uncertainty.

• Annual revenue for 2025 projected at €13 million, representing growth from €11.5 million in 2024.

Outlook and guidance

• Double-digit revenue growth targeted for 2025, with a more favorable outlook for 2026 driven by new product launches and cost optimization.

• First volume orders for natural blue colorant Galdieria Blue expected in 2026 following FDA approval and production ramp-up.